or Try an Advanced Search...

    Technical Analysis for NAYA - NAYA Biosciences, Inc.

    Grade Last Price % Change Price Change
    D 0.81 -0.20% 0.00
    NAYA closed down 4.47 percent on Monday, November 18, 2024, on 1 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical NAYA trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish -0.20%
    MACD Bearish Signal Line Cross Bearish -0.20%
    Boomer Buy Setup Bullish Swing Setup -0.20%
    NR7 Range Contraction -0.20%
    NR7-2 Range Contraction -0.20%
    Narrow Range Bar Range Contraction -0.20%
    Inside Day Range Contraction -0.20%
    Gapped Down Weakness -0.20%
    20 DMA Support Bullish -4.66%
    NR7 Range Contraction -4.66%
    Older End-of-Day Signals for NAYA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 2 hours ago
    Gap Up Closed about 5 hours ago
    60 Minute Opening Range Breakdown about 5 hours ago
    Fell Below Previous Day's Low about 5 hours ago
    Reversed from Up about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NAYA Chart by TradingView
    Basic chart:

    Profile

    NAYA Biosciences, Inc. operates a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on October 14, 2024 and is headquartered in Sarasota, FL.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Autoimmune Disease

    Is NAYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    Oct 24 NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
    Oct 21 INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
    Oct 14 What Happened With Invo BioScience Stock Today?
    Oct 14 INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
    Aug 15 INVO BioScience GAAP EPS of -$0.62, revenue of $1.84M
    Aug 14 INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
    Jul 29 Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
    May 21 INVO Bioscience files for $100M mixed shelf
    See more NAYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.5
    52 Week Low 0.6311
    Average Volume 1,412,179
    200-Day Moving Average 0.90
    50-Day Moving Average 0.78
    20-Day Moving Average 0.84
    10-Day Moving Average 0.84
    Average True Range 0.09
    RSI (14) 48.72
    ADX 35.01
    +DI 27.08
    -DI 14.36
    Chandelier Exit (Long, 3 ATRs) 0.90
    Chandelier Exit (Short, 3 ATRs) 1.00
    Upper Bollinger Bands 0.95
    Lower Bollinger Band 0.73
    Percent B (%b) 0.38
    BandWidth 27.16
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0023
    Fundamentals Value
    Market Cap 2.02 Million
    Num Shares 2.49 Million
    EPS -10.34
    Price-to-Earnings (P/E) Ratio -0.08
    Price-to-Sales 1.22
    Price-to-Book 6.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.87
    Resistance 3 (R3) 0.88 0.86 0.86
    Resistance 2 (R2) 0.86 0.85 0.86 0.86
    Resistance 1 (R1) 0.84 0.84 0.83 0.83 0.86
    Pivot Point 0.82 0.82 0.82 0.82 0.82
    Support 1 (S1) 0.80 0.81 0.79 0.79 0.77
    Support 2 (S2) 0.78 0.80 0.78 0.77
    Support 3 (S3) 0.76 0.78 0.76
    Support 4 (S4) 0.75